TERMINATION AGREEMENTTermination Agreement • August 16th, 2017 • Immunomedics Inc • In vitro & in vivo diagnostic substances • New York
THIS TERMINATION AGREEMENT (this “Termination Agreement”) is made and entered into effective as of the Termination Effective Date by and between IMMUNOMEDICS, INC., a Delaware corporation (“IMMU”), and Seattle Genetics, Inc., a Delaware corporation (“SGEN”). Each of IMMU and SGEN may be referenced herein individually as a “Party” and collectively as the “Parties”.
